Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZymoChem has developed a proprietary microbial platform that enables the efficient conversion of renewable feedstocks into high-value, bio-based materials. Their technology achieves up to a 50% higher yield than traditional biomanufacturing processes and supports fully circular manufacturing. In early 2025, they reached commercial-scale production for key ingredients in their BAYSE™ BioSAP super absorbent polymer product line, targeting sustainability in industries such as hygiene and textiles. They have also secured significant partnerships with major brands like lululemon to develop bio-based nylon alternatives and have received government grants supporting their scale-up efforts[1][4].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZymoChem.